Exactech

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Exactech sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials 5 currently recruiting 1 completed later-stage tilt top decile by trial count

Exactech: 12 sponsored US clinical trials, 5 recruiting.

Exactech sponsors 12 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 1 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Knee Arthroplasty, Total, with 2 trials.

Top-decile sponsor footprint

Exactech ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

12 total, page 1 of 1

RECRUITING

Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)

NCT05849961
RECRUITING

Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up

NCT05703958
RECRUITING

A Post-Market Domestic (US) and International Data Collection to Assess the Truliant Knee System

NCT05653102
RECRUITING

Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only

NCT05619588
RECRUITING

Exactech Shoulder Post Market Clinical Follow-up Study

NCT05603728
ACTIVE NOT RECRUITING

Optetrak Knee System Post Market Clinical Follow-Up

NCT05788757
TERMINATED

Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)

NCT05615246
TERMINATED

Study to Assess Exactech's Guided Personalized Surgery eGPS® in Total Knee Arthroplasty

NCT02962362
TERMINATED NA

Standard Total Knee Arthroplasty Using Platelet Rich Plasma (PRP)

NCT01075230
COMPLETED Phase 4

Platelet Rich Plasma (PRP) in Total Knee Replacement

NCT00826098
TERMINATED NA

Post Approval Study: NOVATION Ceramic Articulation Hip System

NCT00715143
TERMINATED NA

Evaluation of Radiographic and Patient Outcomes Following Lumbar Spine Fusion Using Demineralized Bone Matrix (DBM) Mixed With Autograft

NCT00254852

Phase Distribution

PhaseTrial count
Phase 4 1

Therapeutic Areas

Knee Arthroplasty, Total 2
Non-Union Fracture 1
Fracture Dislocation 1
Osteonecrosis 1
Failure, Prosthesis 1
Arthritis of Ankle 1
Ankle Rheumatoid Arthritis 1
Osteo Arthritis Shoulders 1
Proximal Humeral Fracture 1
Post-traumatic Osteoarthritis 1

Where Exactech enrollment is open (later-stage tilt)

5 recruiting of 12 indexed (42% open); 1 completed (8%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Knee Arthroplasty, Total (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Exactech: open-pipeline peers nationwide

Peers matched on 12 registered trials and 42% open enrollment, not the therapeutic-area sidebar.

Exactech sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 10152025 0%10%20%30%40%50% Total trials Recruiting share ExactechAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.AngiodynamicsArthrexDiwakar DavarInari MedicalMassachusetts Institute of Technology
Exactech sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Exactech sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 trials (± recruiting share)

Sponsors near 42% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Exactech page

12 registered trials is a research-attention snapshot, not an endorsement of Exactech or any single study.

  • 5 of Exactech's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Knee Arthroplasty, Total is the condition Exactech studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Knee Arthroplasty, Total trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Exactech pipeline card: 12 registered trials from official public datasets.Report a data error.